Novo Nordisk’s Miriam Frieden to lead BD at Lundbeck

After 15 years with Novo Nordisk A/S (CSE:NOVO-B; NYSE:NVO) culminating in a position as VP of strategic innovation investments, Miriam Frieden has taken a new position with H. Lundbeck A/S as VP and global head of corporate business development. Frieden led Novo’s iNNvest investment initiative, launched last year.

HHS announced on Monday that Martin Kulldorff has left his position as chairman of CDC’s Advisory Committee on Immunization Practices and will become HHS’s chief scientific officer. Kulldorff was a co-author of the Great Barrington Declaration, a call to lift COVID public health measures before approval of a vaccine. The new ACIP chair is Kirk Milhoan. During the pandemic, Milhoan asserted that COVID vaccines were not effective and advocated relying on natural immunity. ...